LLMpediaThe first transparent, open encyclopedia generated by LLMs

Psychosis

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Alzheimer's disease Hop 4
Expansion Funnel Raw 93 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted93
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Psychosis
NamePsychosis
SynonymsPsychotic episode
FieldPsychiatry, Clinical psychology
SymptomsDelusions, hallucinations, disorganized thinking
ComplicationsSelf-harm, social isolation, substance abuse
OnsetTypically late adolescence, early adulthood
DurationMay be brief or chronic
TypesSchizophrenia, bipolar disorder, major depressive disorder
CausesGenetics, trauma, substance use, medical conditions
RisksFamily history, cannabis use, urban upbringing
DiagnosisBased on symptoms, Mental Status Examination, DSM-5
DifferentialDelirium, dementia, personality disorders
TreatmentAntipsychotic medication, psychotherapy, social support
MedicationRisperidone, olanzapine, clozapine
PrognosisVaries; early intervention improves outcomes
Frequency~3% lifetime prevalence

Psychosis is a mental state characterized by a loss of contact with reality, manifesting primarily through delusions and hallucinations. It is a core feature of several serious mental disorders and can be triggered by various medical, neurological, and substance-related conditions. The experience significantly impairs an individual's perception, thoughts, affect, and behavior, often necessitating clinical intervention.

Definition and overview

The term psychosis broadly describes a collection of symptoms that indicate a disrupted interpretation of reality, rather than constituting a specific diagnosis itself. Historically, the concept was shaped by figures like Emil Kraepelin, who distinguished it from neurosis, and later refined by Eugen Bleuler. It is a key criterion in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) for disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder. The World Health Organization's International Classification of Diseases (ICD-11) also provides diagnostic guidelines for psychotic conditions. The study of psychosis falls primarily within the domains of psychiatry and clinical psychology, with research often conducted at institutions like the National Institute of Mental Health.

Causes and risk factors

The etiology of psychosis is multifactorial, involving complex interactions between genetic, neurobiological, and environmental factors. A strong family history of psychotic disorders, particularly schizophrenia, is a significant risk factor, with studies implicating variations in genes related to dopamine and glutamate neurotransmission. Prenatal exposures, such as complications during birth or maternal infection, may increase vulnerability. Environmental stressors include childhood trauma, urban upbringing, and migration experiences, as documented in research from places like the Institute of Psychiatry, Psychology and Neuroscience. Substance use, especially cannabis and stimulants like methamphetamine, can induce or exacerbate psychotic symptoms. Medical conditions such as brain tumors, epilepsy (particularly of the temporal lobe), neurodegenerative diseases like Huntington's disease, and autoimmune disorders like lupus are also recognized causes.

Signs and symptoms

The primary symptoms of psychosis are categorized as positive, negative, and cognitive. Positive symptoms reflect an excess or distortion of normal functions, most notably delusions (fixed false beliefs, such as paranoia or grandiosity) and hallucinations (perceptions without external stimulus, often auditory). Negative symptoms involve a diminution of normal functions, including avolition (lack of motivation), alogia (poverty of speech), and anhedonia (inability to feel pleasure). Disorganized symptoms encompass disorganized speech, such as derailment or incoherence, and disorganized behavior, which can range from agitation to catatonia. Mood symptoms, like those seen in major depressive disorder or bipolar disorder, frequently co-occur. The first episode often presents during late adolescence or early adulthood, a period sometimes termed the prodrome.

Diagnosis and assessment

Diagnosis is clinical, based primarily on a detailed history and Mental Status Examination conducted by a psychiatrist or other qualified mental health professional. Standardized diagnostic criteria are outlined in the DSM-5 and ICD-11. Tools like the Structured Clinical Interview for DSM Disorders (SCID) and rating scales such as the Positive and Negative Syndrome Scale (PANSS) are used for systematic assessment. It is crucial to rule out other medical causes; this often involves physical examinations, blood tests, and neuroimaging (e.g., MRI or CT scan) to exclude conditions like delirium, dementia, or metabolic disturbances. Differential diagnosis also considers substance-induced psychotic disorder and psychotic features within borderline personality disorder.

Treatment and management

Treatment typically involves a combination of antipsychotic medication, psychotherapy, and psychosocial support. First-line pharmacological agents are second-generation antipsychotics like risperidone, olanzapine, and aripiprazole, though first-generation antipsychotics such as haloperidol are also used. For treatment-resistant cases, clozapine is often prescribed. Psychotherapeutic approaches include cognitive behavioral therapy for psychosis (CBTp) and family intervention. Coordinated specialty care programs, such as the RAISE initiative supported by the National Institute of Mental Health, emphasize early intervention. Psychosocial rehabilitation, provided through Assertive Community Treatment teams or clubhouse model programs like Fountain House, focuses on improving social and vocational functioning. In acute settings, hospitalization may be necessary to ensure safety.

Prognosis and epidemiology

The course and outcome of psychosis vary widely. Epidemiological studies, including those by the World Health Organization, suggest a lifetime prevalence of approximately 3%. Prognosis is influenced by factors such as rapidity of treatment initiation, with early intervention services like those in Australia and Scandinavia showing improved outcomes. Co-occurring substance abuse and poor adherence to medication often worsen the long-term trajectory. While some individuals experience a single episode with full recovery, others may develop chronic conditions like schizophrenia, which can involve significant disability. Stigma and discrimination, addressed by movements like Time to Change in the United Kingdom, remain substantial barriers to social integration and recovery.